Soren Neve

Title: Soren Neve: Innovator in Antimicrobial Peptides and Connexin Modulation

Introduction

Soren Neve is a distinguished inventor based in Lyngby, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of antimicrobial peptides and methods for modulating connexin hemichannels. With a total of 2 patents, Neve's work has the potential to impact various therapeutic applications.

Latest Patents

Soren Neve's latest patents include innovative advancements in antimicrobial peptides. The first patent, titled "Antimicrobial peptide variants and polynucleotides encoding same," focuses on variants of a parent antimicrobial peptide. This invention also encompasses polynucleotides that encode these variants, along with nucleic acid constructs, vectors, and host cells that utilize these polynucleotides. The second patent, "Compositions and methods for modulating connexin hemichannels," discloses compositions and methods aimed at modulating hemichannel function in cells, tissues, or organs. This invention is particularly relevant for developing therapeutic methods to prevent or treat conditions such as heart arrhythmia, which are influenced by undesired hemichannel function.

Career Highlights

Throughout his career, Soren Neve has worked with notable companies in the biotechnology sector, including Wyeth and Adenium Biotech. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative research.

Collaborations

Soren Neve has collaborated with esteemed colleagues such as Peter Holme Jensen and Bjarne Due Larsen. These partnerships have likely enriched his research and development efforts, leading to impactful inventions.

Conclusion

Soren Neve's contributions to the fields of antimicrobial peptides and connexin modulation highlight his role as a significant innovator in biotechnology. His patents reflect a commitment to advancing therapeutic solutions that can improve health outcomes.